🔎 Trials Near Me

Home › Macular Degeneration › North Carolina

Macular Degeneration clinical trials in North Carolina

11 studies for Macular Degeneration are looking for participants at sites in North Carolina.

Cities in North Carolina

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Piedmont Retina Specialists - Greensboro, Greensboro
  • North Carolina Retina Associates, Greenville
  • Piedmont Retina Specialists - Winston-Salem, Winston-Salem
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Asheville Eye Associates - Western Carolina Retinal Associates, Asheville
  • Duke Eye Center, Durham
  • Graystone Eye, Hickory
  • and 1 more
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • NC Retina Associates, Cary
  • Graystone Eye, Hickory
  • North Carolina Retina Associates, Wake Forest
  • and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • North Carolina Retina Associates, Cary
  • Duke Eye Center, Durham
  • North Carolina Retina Associates, Greenville
  • and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • Duke Eye Center, Durham
RecruitingObservational study
Ages 55 and older · All sexes · Updated Sep 3, 2026 · NCT07144137

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • Duke Eye Center, Durham
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

  • Duke Eye Center, Durham
RecruitingHealthy volunteers welcome
Ages 50 to 89 · All sexes · Updated Aug 10, 2026 · NCT06619405

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Asheville Eye Associates, Retina Division (Site 077), Asheville
  • NC Retina, Cary
  • Graystone Eye, Hickory
  • and 1 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

  • Wake Forest, NC, Wake Forest
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 7, 2026 · NCT07587515

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • North Carolina Retina Associates, Cary
  • North Carolina Retina Associates, Wake Forest
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Western Carolina Retinal Associates, Asheville
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.